EUVIMEDEUVIMED entdecken
Crossref

Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio

Guanmin Chen, Clarence W Chan, Richard F Schaefer, Sarosh Rana, Kiang-Teck J Yeo iD

American Journal of Clinical Pathology · 2025

DOI: 10.1093/ajcp/aqaf032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Guanmin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Section of Clinical Chemistry, University of Chicago, Chicago, IL, United States. Hauptthemen laut MEDLINE: Pre-Eclampsia, Vascular Endothelial Growth Factor Receptor-1, Placenta Growth Factor. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The US Food and Drug Administration recently approved the ratio of soluble FMS-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) using the Thermo Fisher Scientific B·R·A·H·M·S KRYPTOR autoanalyzer—the first preeclampsia marker used for clinical testing. We evaluated the analytical precision of the sFlt-1 and PlGF assays, focusing on the effects of PlGF imprecision on the sFlt-1 to PlGF ratio interpretation and clinical reliability for preeclampsia risk assessment.

Methods

We measured sFlt-1 and PlGF on the KRYPTOR instrument using a homogeneous sandwich fluoroimmunoassay. Between-day precision was assessed using 3 levels of commercial quality control (QC) materials and analyzed over 3 months. In all, 180 samples obtained from 161 hospitalized pregnant women were analyzed to assess the relationship between PlGF levels and the sFlt-1 to PlGF ratio.

Results

The sFlt-1 assay demonstrated good precision (coefficient of variation (s/x̄) × 100 [CV] = approximately 3.0%) across all QC levels, while the PlGF assay exhibited higher imprecision, particularly at low QC levels (CV = 7.7%-11.3%). Long-term QC monitoring revealed a downward drift in PlGF values, with improved stability after reagent lot changes. Despite higher imprecision at lower PlGF levels (23.1-34.7 ng/L), the clinical interpretation of the sFlt-1 to PlGF ratio remained robust because low PlGF consistently correlated with ratios well above the critical cutoff of 40.

Conclusions

Despite the suboptimal precision observed at low QC levels and potential drifts in PlGF results, the sFlt-1 to PlGF ratio remains a reliable tool for preeclampsia risk assessment. This study highlights the need for critical evaluation of analytical performance beyond FDA approval and the importance of assessing the potential impact of assay imprecision on patient care for individual biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaVascular Endothelial Growth Factor Receptor-1Placenta Growth FactorHumansFemalePregnancyImmunoassayRisk AssessmentBiomarkersAdultReproducibility of Results

Stichwörter der Autor:innen

biomarkerimprecisionpreeclampsiaquality controlsFlt-1 to PlGF ratio

Substanzen

Vascular Endothelial Growth Factor Receptor-1Placenta Growth FactorFLT1 protein, humanPGF protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Pathology, Section of Clinical Chemistry, University of Chicago, Chicago, IL, United States.
  • Pritzker School of Medicine, University of Chicago, Chicago, IL, United States.
  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Chicago, Chicago, IL, United States.

ORCID-Profile: Kiang-Teck J Yeo

Zitieren

APA

Chen, G., Chan, C. W., Schaefer, R. F., Rana, S., & Yeo, K. J. (2025). Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqaf032

Vancouver

Chen G, Chan CW, Schaefer RF, Rana S, Yeo KJ. Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqaf032

BibTeX
@article{Chen2025,
  author = {Chen, Guanmin and Chan, Clarence W and Schaefer, Richard F and Rana, Sarosh and Yeo, Kiang-Teck J},
  title = {Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio},
  journal = {American Journal of Clinical Pathology},
  year = {2025},
  doi = {10.1093/ajcp/aqaf032}
}
Kostenlos starten →